Getinge

215.2

SEK

+0.33 %

GETI B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Less than 1K followers

+0.33%

+18.53%

+18.53%

+13.68%

+10.3%

+8.8%

-41.59%

+24.75%

+2,617.75%

Getinge is a global medical technology company that specializes in providing equipment and IT systems to the healthcare and life science industry. The company offers, among other things, solutions for operating theatres, intensive care units, sterilization centers and drug development. The company was founded in 1904 and has its headquarters in Gothenburg.

Market cap

58.61B SEK

Turnover

168.47M SEK

Revenue

34.76B

EBIT %

8.21 %

P/E

35.81

Dividend yield-%

2.14 %

Financial calendar

22.4

2025

General meeting '25

22.4

2025

Interim report Q1'25

23.4

2025

Annual dividend

ShowingAll content types

Getinge, Audiocast with teleconference, Q4'24

Webcast1/28/2025, 9:00 AM

Getinge, Audiocast with teleconference, Q4'24

Regulatory press release1/28/2025, 7:00 AM

Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins

Press release1/23/2025, 2:00 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q4 2024

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release1/14/2025, 7:00 AM

Getinge invites fund managers, analysts, and media to Year-End Report 2024 conference call

Regulatory press release11/28/2024, 12:00 PM

Changes of the Nomination Committee of Getinge

Regulatory press release11/7/2024, 1:00 PM

Alexandra Holland appointed as EVP Communications at Getinge

Getinge AB, Audiocast with teleconference, Q3'24

Webcast10/18/2024, 8:00 AM

Getinge AB, Audiocast with teleconference, Q3'24

Regulatory press release10/18/2024, 6:00 AM

Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

Press release10/15/2024, 1:30 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q3 2024

Press release10/4/2024, 6:00 AM

Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call

Press release9/25/2024, 2:07 PM

Getinge's CE certificate for ECLS consumables reinstated

Press release9/11/2024, 12:57 PM

Getinge completes the acquisition of Paragonix Technologies

Regulatory press release9/1/2024, 6:04 PM

Getinge makes a provision of MBRL 240 related to Brazilian investigation

Regulatory press release8/22/2024, 8:23 PM

Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Getinge AB, Audiocast with teleconference, Q2'24

Webcast7/18/2024, 8:00 AM

Getinge AB, Audiocast with teleconference, Q2'24

Regulatory press release7/18/2024, 6:00 AM

Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers

Press release7/15/2024, 12:30 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q2 2024

Press release7/1/2024, 6:00 AM

Getinge invites fund managers, analysts, and media to Q2 Report 2024 conference call

Getinge, Audiocast with teleconference, 2024

Webcast5/15/2024, 8:00 AM

Getinge, Audiocast with teleconference, 2024

Regulatory press release5/14/2024, 6:15 PM

Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.